This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Radafaxine

GlaxoSmithKline plc

Drug Names(s): 353162, GSK162

Description: Radafaxine (a metabolite of bupropion) is a norepinephrine reuptake inhibitor and weak dopamine reuptake inhibitor. By inhibiting reuptake, the neurotransmitters remain in the synapses between neurons for a longer time and have have a greater effect on mood.


Radafaxine News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug